These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29439855)

  • 1. Catechol-O-methyltransferase (COMT) genetic variants are associated with cognitive decline in patients with Parkinson's disease.
    Lin CH; Fan JY; Lin HI; Chang CW; Wu YR
    Parkinsonism Relat Disord; 2018 May; 50():48-53. PubMed ID: 29439855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
    Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson's disease.
    Lin CH; Chaudhuri KR; Fan JY; Ko CI; Rizos A; Chang CW; Lin HI; Wu YR
    Sci Rep; 2017 Jul; 7(1):6306. PubMed ID: 28740224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of functional catechol-O-methyltransferase genotypes in Chinese patients with Parkinson's disease.
    Xiao Q; Qian Y; Liu J; Xu S; Yang X
    Transl Neurodegener; 2017; 6():11. PubMed ID: 28451382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease.
    Bäckström D; Eriksson Domellöf M; Granåsen G; Linder J; Mayans S; Elgh E; Zetterberg H; Blennow K; Forsgren L
    Acta Neurol Scand; 2018 Jan; 137(1):91-98. PubMed ID: 28869277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.
    Paul KC; Rausch R; Creek MM; Sinsheimer JS; Bronstein JM; Bordelon Y; Ritz B
    J Parkinsons Dis; 2016 Apr; 6(2):349-59. PubMed ID: 27061069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMT gene haplotypes are closely associated with postoperative fentanyl dose in patients.
    Zhang F; Tong J; Hu J; Zhang H; Ouyang W; Huang D; Tang Q; Liao Q
    Anesth Analg; 2015 Apr; 120(4):933-40. PubMed ID: 25532715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Catechol-O-Methyltransferase Gene Polymorphisms and Haplotypes in the Levodopa-Induced Adverse Events in Subjects with Parkinson's Disease.
    Fatima TS; Fathima ST; Kandadai RM; Borgohain R; Sreenu B; Kutala VK
    Indian J Clin Biochem; 2023 Apr; 38(2):262-274. PubMed ID: 37025429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between catechol O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in adults.
    Halleland H; Lundervold AJ; Halmøy A; Haavik J; Johansson S
    Am J Med Genet B Neuropsychiatr Genet; 2009 Apr; 150B(3):403-10. PubMed ID: 18802928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic denervation severity depends on COMT Val158Met polymorphism in Parkinson's disease.
    Muellner J; Gharrad I; Habert MO; Kas A; Martini JB; Cormier-Dequaire F; Tahiri K; Vidailhet M; Meier N; Brice A; Schuepbach M; Mallet A; Hartmann A; Corvol JC
    Parkinsonism Relat Disord; 2015 May; 21(5):471-6. PubMed ID: 25753458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic influences on cognitive decline in Parkinson's disease.
    Morley JF; Xie SX; Hurtig HI; Stern MB; Colcher A; Horn S; Dahodwala N; Duda JE; Weintraub D; Chen-Plotkin AS; Van Deerlin V; Falcone D; Siderowf A
    Mov Disord; 2012 Apr; 27(4):512-8. PubMed ID: 22344634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational study.
    Chung J; Ushakova A; Doitsidou M; Tzoulis C; Tysnes OB; Dalen I; Pedersen KF; Alves G; Maple-Grødem J
    Neurosci Lett; 2021 Nov; 764():136243. PubMed ID: 34509566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol O-methyltransferase (COMT) functional haplotype is associated with recurrence of affective symptoms: A prospective birth cohort study.
    Koike S; Gaysina D; Jones PB; Wong A; Richards M
    J Affect Disord; 2018 Mar; 229():437-442. PubMed ID: 29331705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase gene (COMT) is associated with neurocognitive functioning in patients with sickle cell disease.
    Heitzer AM; Rashkin SR; Trpchevska A; Longoria JN; Rampersaud E; Olufadi Y; Wang WC; Raches D; Potter B; Steinberg MH; King AA; Kang G; Takemoto CM; Hankins JS
    Curr Res Transl Med; 2024 Jun; 72(2):103433. PubMed ID: 38244277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMT Val158Met variant and functional haplotypes associated with childhood ADHD history in women with bulimia nervosa.
    Yilmaz Z; Kaplan AS; Zai CC; Levitan RD; Kennedy JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):948-52. PubMed ID: 21300128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced gray matter volume in cognitively preserved COMT
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Brain Imaging Behav; 2020 Apr; 14(2):321-328. PubMed ID: 30612340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.
    Williams-Gray CH; Evans JR; Goris A; Foltynie T; Ban M; Robbins TW; Brayne C; Kolachana BS; Weinberger DR; Sawcer SJ; Barker RA
    Brain; 2009 Nov; 132(Pt 11):2958-69. PubMed ID: 19812213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.